Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Charlie Hospital Semarang Tbk (RSCH) Fair Value & Analysis

Healthcare · ID · Market cap 710B IDR

Price322.00 IDR
Fair Value147.76 IDR
Upside-54.1%
Quality91/100
Evidence: Low Range 110.82 IDR – 184.70 IDR

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

PT Charlie Hospital Semarang Tbk (RSCH) currently trades at 322.00 IDR, while our model-based Fair Value estimate is 147.76 IDR — implying the stock looks roughly 54.1% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

PT Charlie Hospital Semarang Tbk operates private hospitals in Indonesia. It operates through Healthcare Services, Construction Services, and Construction Materials Trading segments. The company's hospitals offer outpatients and inpatient services, including a 24-hour emergency room, specialist polyclinic services, central surgical installation services, intensive care units, Perina, laboratory services, radiology services, pharmacy services, medical checkup and support services, wellness centers, and other supporting facilities. It also engages in the construction, maintenance, and reconstruction of residential, office, industrial, commercial, healthcare, educational, lodging, entertainment/sports, and other buildings; and trading of construction materials. The company was founded in 2019 and is headquartered in Kendal, Indonesia. PT Charlie Hospital Semarang Tbk operates as a subsidiary of PT Wahyu Agung.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) +19% Fresenius SE (FSNUY) -24% 5225 (5225) -39% IHHHF (IHHHF) -57% Rede D'Or São Luiz S.A (RDOR3) +37% Tenet Healthcare Corporation (THC) +86%

Frequently asked questions

Is PT Charlie Hospital Semarang Tbk (RSCH) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 147.76 IDR versus a price of 322.00 IDR — about −54% (overvalued). Model-based estimate, not financial advice.
What is the fair value of RSCH?
Our 21-model fair value for PT Charlie Hospital Semarang Tbk is 147.76 IDR (as of Jun 24, 2026), built from audited fundamentals. The current price is 322.00 IDR.
What is the quality score of RSCH?
PT Charlie Hospital Semarang Tbk has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.